The Role of Complement in Inflammation

Cochrane, 1968, The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement, J Exp Med, 127, 371, 10.1084/jem.127.2.371 Davis, 1981, The Neutrophil, 77 Fearon, 1975, Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase, J Exp Med, 142, 856, 10.1084/jem.142.4.856 Fearon, 1983, Complement ligand-receptor interactions that mediate biological responses, Annu Rev Immunol, 1, 243, 10.1146/annurev.iy.01.040183.001331 Fernandez, 1978, Chemotactiv response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions, J Immunol, 120, 109 Gewurz, 1968, Interactions of the complement system with endotoxin lipopolysaccharide: consumption of each of the six terminal complement components, J Exp Med, 128, 1049, 10.1084/jem.128.5.1049 Ghebrehiwet, 1979, C3e: An acidic fragment of human C3 with leukocytosis-inducing activity, J Immunol, 123, 616 Goldstein, 1976, Polymorphonuclear leukocyte lysosomes and immune tissue injury, Prog Allergy, 20, 301, 10.1159/000313411 Grossklaus, 1976, Induction of platelet aggregation by the complement-derived peptides C3a and C5a, Naunyn Schmiedebergs Arch Pharmakol, 295, 71, 10.1007/BF00509775 Hadding, 1983, Peritoneal macrophages release prostaglandin E and thromboxane B2 in response to C3b, 531 Hänsch, 1980, Effect of aspirin on the complement system in vitro, Int Archs Allergy appl Immun, 61, 150, 10.1159/000232428 Hartung, 1983, Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77, J Immunol, 130, 1345 Henson, 1971, The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles, J Immunol, 107, 1535 Hugli, 1981, The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a, CRC Crit Rev Immunol, 1, 321 Inoue, 1977, Release of phospholipids from complement-mediated lesions on the surface structure of Escherichia coli, J Immunol, 119, 65 Kolb, 1972, Molecular analysis of the membrane attack mechanism of complement, J Exp Med, 135, 549, 10.1084/jem.135.3.549 Kunze, 1982, Effects of antimalarial drugs on several rat liver lysosomal enzymes involved in phosphatidyl ethanolamine catabolism, Biochem Biophys Acta, 713, 112, 10.1016/0005-2760(82)90173-4 Lieberknecht, 1981, Der lytische Komplement-Komplex als pathogenes Agens bei der IgA-Nephropathie Maly, 1983, C5a-induced chemiluminescence of human granulocytes and its amplification by a serum factor, Immunobiol, 164, 90, 10.1016/S0171-2985(83)80021-7 Messner, 1970, Receptors for human γG-globulin on human neutrophils, J Clin Invest, 49, 2165, 10.1172/JCI106435 Meuth, 1983, Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b, J Immunol, 130, 2605 Mota, 1957, Action of anaphylactic shock and anaphylatoxin on mast cells and histamine in rats, Br J Pharmacol, 12, 453 Müller-Eberhard, 1967, Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement, J Exp Med, 125, 359, 10.1084/jem.125.2.359 Müller-Eberhard, 1982, The unusual functional and structural versatility of C3 and the initiation of the alternative complement pathway, 399 Palitzsch, 1983 Pfueller, 1972, The effects of immune complexes on blood platelets and their relationship to complement activation, Immunochemistry, 9, 1151, 10.1016/0019-2791(72)90085-7 Polley, 1978, The human complement system in thrombin-mediated platelet function, J Exp Med, 147, 1713, 10.1084/jem.147.6.1713 Polley, 1979, Human complement in thrombin-mediated platelet function. Uptake of the C5b-9 complex, J Exp Med, 150, 633, 10.1084/jem.150.3.633 Polley, 1983, Human platelet activation by C3a and C3a des-arg, J Exp Med, 158, 603, 10.1084/jem.158.2.603 Reid, 1983, Structural and functional studies on: (1) normal C1q; (2) A defective form of C1q; (3) C4 binding protein. (C3bp), 9 Rother, 1972, Leukocyte mobilizing factor: a new biological activity derived from the third component of complement, Eur J Immunol, 2, 550, 10.1002/eji.1830020615 Rother, 1978, The leukocytosis reaction: Complexity of the complement-derived leukocyte mobilizing factor (LMF), Z Immunitätsforsch, 155, 55 Rother, 1964, Passive Arthus-Reaktion bei Komplement-defekten Kaninchen, Z Immunitätsforsch Allergy, 126, 473 Rother, 1980, The Complement System, Vol. 2, 71 Whaley, 1976, C3b inactivator accelerator: a serum co-factor for C3b inactivator necessary for full expression of its activity, J Immunol, 116, 1754